Sertraline hydrochloride tablets are indicated for the treatment of symptoms related to depression, including depression with anxiety, with or without a history of mania.
This report contains market size and forecasts of Sertraline Hydrochloride Tablet in global, including the following market information:
Global Sertraline Hydrochloride Tablet Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Sertraline Hydrochloride Tablet Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Sertraline Hydrochloride Tablet companies in 2021 (%)
The global Sertraline Hydrochloride Tablet market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Generic Grugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sertraline Hydrochloride Tablet include PIDI, Cy Pharm, HENGSHAN PHARMACEYTICAL, JINGXIN PHARMACEUTICAL, Hainan Healthcare Pharma, Pfizer, Accord-Healthcare., Exelan Pharmaceuticals and Greenstone, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sertraline Hydrochloride Tablet manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sertraline Hydrochloride Tablet Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Sertraline Hydrochloride Tablet Market Segment Percentages, by Type, 2021 (%)
Generic Grugs
Patent Medicine
Others
Global Sertraline Hydrochloride Tablet Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Sertraline Hydrochloride Tablet Market Segment Percentages, by Application, 2021 (%)
Treat Depression
Treat Obsessive-Compulsive Disorder
Treat Anxiety
Others
Global Sertraline Hydrochloride Tablet Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Sertraline Hydrochloride Tablet Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sertraline Hydrochloride Tablet revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Sertraline Hydrochloride Tablet revenues share in global market, 2021 (%)
Key companies Sertraline Hydrochloride Tablet sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Sertraline Hydrochloride Tablet sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
PIDI
Cy Pharm
HENGSHAN PHARMACEYTICAL
JINGXIN PHARMACEUTICAL
Hainan Healthcare Pharma
Pfizer
Accord-Healthcare.
Exelan Pharmaceuticals
Greenstone
Cipla USA Lnc
Lupin